Literature DB >> 3767132

Airways hyperreactivity and inflammation produced by aerosolization of human C5A des arg.

C G Irvin, N Berend, P M Henson.   

Abstract

The premise of this study was that complement fragments would lead to granulocyte infiltration and to associated changes in airways reactivity. Inflammation was induced in large airways (greater than 1.0 mm) by aerosolization of the complement chemotactic factor, C5a des arg, which was isolated from activated human serum. Pulmonary function (resistance, compliance, and lung volume) and histamine reactivity were assessed at 4 and at 48 h after C5a des arg or a saline sham aerosol. Four hours after exposure to C5a des arg, the animals exhibited evidence of significant bronchoconstriction and hyperinflation. In addition, an increased responsiveness to histamine was demonstrated, which was not correlated with the degree of bronchospasm. By 48 h, these alterations were partially or completely resolved. Histologic examination and quantitation demonstrated significant accumulation of neutrophils, which was limited to airways 0.5 mm in or larger. Saline-treated animals also demonstrated a neutrophil infiltration, but significantly less than those treated with C5a des arg. However, these animals did not demonstrate hyperreactivity to histamine, and there was little change in baseline mechanical function. The mild inflammation associated in the saline control animals was demonstrated to be a result of intubation of the airways. Granulocyte dependence of the effects of C5a des arg was partially established by abrogation of these effects when the animals were rendered granulocytopenic with nitrogen mustard. We conclude that the physiologic responses of the airways to C5a des arg were largely granulocyte dependent. However, since granulocyte accumulation could occur without airways dysfunction, it is suggested that cell activation is an important step in producing neutrophil-associated airways hyperresponsiveness.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3767132     DOI: 10.1164/arrd.1986.134.4.777

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

1.  The effect of L-glutamic acid on airway function and reactivity in the rabbit.

Authors:  A Nicholson; C L Phillips; D H Allen; H E Ward; N Berend
Journal:  Agents Actions       Date:  1988-12

2.  Effect of inhaled formyl-methionyl-leucyl-phenylalanine on airway function.

Authors:  N Berend; M J Peters; C L Armour; J L Black; H E Ward
Journal:  Thorax       Date:  1988-01       Impact factor: 9.139

Review 3.  PAF antagonists. Their potential therapeutic role in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Drugs       Date:  1988-02       Impact factor: 9.546

4.  Effect of an oral gold compound, auranofin, on non-specific bronchial hyperresponsiveness in mild asthma.

Authors:  M Honma; G Tamura; K Shirato; T Takishima
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

5.  Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response.

Authors:  Tao Peng; Liming Hao; Joseph A Madri; Xiao Su; Jack A Elias; Gregory L Stahl; Stephen Squinto; Yi Wang
Journal:  J Clin Invest       Date:  2005-05-12       Impact factor: 14.808

6.  Trimellitic anhydride-induced allergic response in the lung: role of the complement system in cellular changes.

Authors:  D G Fraser; J F Regal; M L Arndt
Journal:  J Pharmacol Exp Ther       Date:  1995-05       Impact factor: 4.030

7.  Repeated episodes of C5a-induced neutrophil influx do not result in pulmonary fibrosis.

Authors:  J A Harris; D M Hyde; Q J Wang; M Y Stovall; S N Giri
Journal:  Inflammation       Date:  1991-06       Impact factor: 4.092

8.  Body temperature modulates the effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit.

Authors:  M M Nieminen; M Hill; C G Irvin
Journal:  Agents Actions       Date:  1991-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.